Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy : a quantitative cardiac perfusion positron emission tomography study. / Christensen, Thomas Emil; Ahtarovski, Kiril Aleksov; Bang, Lia Evi; Holmvang, Lene; Søholm, Helle; Ghotbi, Adam Ali; Andersson, Hedvig; Vejlstrup, Niels; Ihlemann, Nikolaj; Engstrøm, Thomas; Kjær, Andreas; Hasbak, Philip.

In: European Heart Journal Cardiovascular Imaging, Vol. 16, No. 10, 10.2015, p. 1162-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, TE, Ahtarovski, KA, Bang, LE, Holmvang, L, Søholm, H, Ghotbi, AA, Andersson, H, Vejlstrup, N, Ihlemann, N, Engstrøm, T, Kjær, A & Hasbak, P 2015, 'Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study', European Heart Journal Cardiovascular Imaging, vol. 16, no. 10, pp. 1162-9. https://doi.org/10.1093/ehjci/jev065

APA

Christensen, T. E., Ahtarovski, K. A., Bang, L. E., Holmvang, L., Søholm, H., Ghotbi, A. A., Andersson, H., Vejlstrup, N., Ihlemann, N., Engstrøm, T., Kjær, A., & Hasbak, P. (2015). Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study. European Heart Journal Cardiovascular Imaging, 16(10), 1162-9. https://doi.org/10.1093/ehjci/jev065

Vancouver

Christensen TE, Ahtarovski KA, Bang LE, Holmvang L, Søholm H, Ghotbi AA et al. Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study. European Heart Journal Cardiovascular Imaging. 2015 Oct;16(10):1162-9. https://doi.org/10.1093/ehjci/jev065

Author

Christensen, Thomas Emil ; Ahtarovski, Kiril Aleksov ; Bang, Lia Evi ; Holmvang, Lene ; Søholm, Helle ; Ghotbi, Adam Ali ; Andersson, Hedvig ; Vejlstrup, Niels ; Ihlemann, Nikolaj ; Engstrøm, Thomas ; Kjær, Andreas ; Hasbak, Philip. / Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy : a quantitative cardiac perfusion positron emission tomography study. In: European Heart Journal Cardiovascular Imaging. 2015 ; Vol. 16, No. 10. pp. 1162-9.

Bibtex

@article{2a8f921ec88e4b8f92fabb02be29f530,
title = "Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy: a quantitative cardiac perfusion positron emission tomography study",
abstract = "AIMS: Takotsubo cardiomyopathy (TTC) is characterized by acute completely reversible regional left ventricle (LV) akinesia and decreased tracer uptake in the akinetic region on semi-quantitative perfusion imaging. The latter may be due to normoperfusion of the akinetic mid/apical area and basal hyperperfusion. Our aim was to examine abnormalities of perfusion in TTC, and we hypothesized that basal hyperperfusion is the primary perfusion abnormality in the acute state.METHOD AND RESULTS: Twenty-five patients were diagnosed with TTC due to (i) acute onset of symptoms, (ii) typical apical ballooning, (iii) absence of significant coronary disease, and (iv) complete remission on 4-month follow-up. The patients underwent coronary angiography (CAG), echocardiography, cardiac magnetic resonance imaging (CMR), and (13)NH3/(82)Rb positron emission tomography (PET) in the acute state and-except CAG-on follow-up. Patients initially had severe heart failure, mid/apical oedema but no infarction, and a rise in cardiac biomarkers. On initial perfusion PET imaging, eight patients appeared to have normal, whereas 17 patients had impaired LV perfusion. In the latter, flow in the basal region was increased in the acute state (1.5 ± 0.1 vs. 1.2 ± 0.1 mL/g/minRPP-corrected, P < 0.01), whereas midventricular (1.7 ± 0.1 vs. 1.6 ± 0.1 mL/g/minRPP-corrected, P = 0.21) and apical (1.4 ± 0.1 vs. 1.5 ± 0.1 mL/g/minRPP-corrected, P = 0.36) flow was unchanged between acute and follow-up, and within normal range.CONCLUSION: Our results suggest an abnormal LV perfusion distribution in the acute state of TTC with basal hyperperfusion and a normoperfused akinetic region. The proportion of patients without visualized perfusion abnormalities in the acute state may represent a subgroup with fast remission.",
keywords = "Aged, Biomarkers, Coronary Angiography, Echocardiography, Electrocardiography, Female, Humans, Hyperemia, Magnetic Resonance Imaging, Male, Myocardial Perfusion Imaging, Positron-Emission Tomography, Radiopharmaceuticals, Rubidium Radioisotopes, Takotsubo Cardiomyopathy, Ventricular Dysfunction, Left",
author = "Christensen, {Thomas Emil} and Ahtarovski, {Kiril Aleksov} and Bang, {Lia Evi} and Lene Holmvang and Helle S{\o}holm and Ghotbi, {Adam Ali} and Hedvig Andersson and Niels Vejlstrup and Nikolaj Ihlemann and Thomas Engstr{\o}m and Andreas Kj{\ae}r and Philip Hasbak",
note = "Published on behalf of the European Society of Cardiology. All rights reserved. {\textcopyright} The Author 2015. For permissions please email: journals.permissions@oup.com.",
year = "2015",
month = oct,
doi = "10.1093/ehjci/jev065",
language = "English",
volume = "16",
pages = "1162--9",
journal = "European Heart Journal Cardiovascular Imaging",
issn = "2047-2404",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Basal hyperaemia is the primary abnormality of perfusion in Takotsubo cardiomyopathy

T2 - a quantitative cardiac perfusion positron emission tomography study

AU - Christensen, Thomas Emil

AU - Ahtarovski, Kiril Aleksov

AU - Bang, Lia Evi

AU - Holmvang, Lene

AU - Søholm, Helle

AU - Ghotbi, Adam Ali

AU - Andersson, Hedvig

AU - Vejlstrup, Niels

AU - Ihlemann, Nikolaj

AU - Engstrøm, Thomas

AU - Kjær, Andreas

AU - Hasbak, Philip

N1 - Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.

PY - 2015/10

Y1 - 2015/10

N2 - AIMS: Takotsubo cardiomyopathy (TTC) is characterized by acute completely reversible regional left ventricle (LV) akinesia and decreased tracer uptake in the akinetic region on semi-quantitative perfusion imaging. The latter may be due to normoperfusion of the akinetic mid/apical area and basal hyperperfusion. Our aim was to examine abnormalities of perfusion in TTC, and we hypothesized that basal hyperperfusion is the primary perfusion abnormality in the acute state.METHOD AND RESULTS: Twenty-five patients were diagnosed with TTC due to (i) acute onset of symptoms, (ii) typical apical ballooning, (iii) absence of significant coronary disease, and (iv) complete remission on 4-month follow-up. The patients underwent coronary angiography (CAG), echocardiography, cardiac magnetic resonance imaging (CMR), and (13)NH3/(82)Rb positron emission tomography (PET) in the acute state and-except CAG-on follow-up. Patients initially had severe heart failure, mid/apical oedema but no infarction, and a rise in cardiac biomarkers. On initial perfusion PET imaging, eight patients appeared to have normal, whereas 17 patients had impaired LV perfusion. In the latter, flow in the basal region was increased in the acute state (1.5 ± 0.1 vs. 1.2 ± 0.1 mL/g/minRPP-corrected, P < 0.01), whereas midventricular (1.7 ± 0.1 vs. 1.6 ± 0.1 mL/g/minRPP-corrected, P = 0.21) and apical (1.4 ± 0.1 vs. 1.5 ± 0.1 mL/g/minRPP-corrected, P = 0.36) flow was unchanged between acute and follow-up, and within normal range.CONCLUSION: Our results suggest an abnormal LV perfusion distribution in the acute state of TTC with basal hyperperfusion and a normoperfused akinetic region. The proportion of patients without visualized perfusion abnormalities in the acute state may represent a subgroup with fast remission.

AB - AIMS: Takotsubo cardiomyopathy (TTC) is characterized by acute completely reversible regional left ventricle (LV) akinesia and decreased tracer uptake in the akinetic region on semi-quantitative perfusion imaging. The latter may be due to normoperfusion of the akinetic mid/apical area and basal hyperperfusion. Our aim was to examine abnormalities of perfusion in TTC, and we hypothesized that basal hyperperfusion is the primary perfusion abnormality in the acute state.METHOD AND RESULTS: Twenty-five patients were diagnosed with TTC due to (i) acute onset of symptoms, (ii) typical apical ballooning, (iii) absence of significant coronary disease, and (iv) complete remission on 4-month follow-up. The patients underwent coronary angiography (CAG), echocardiography, cardiac magnetic resonance imaging (CMR), and (13)NH3/(82)Rb positron emission tomography (PET) in the acute state and-except CAG-on follow-up. Patients initially had severe heart failure, mid/apical oedema but no infarction, and a rise in cardiac biomarkers. On initial perfusion PET imaging, eight patients appeared to have normal, whereas 17 patients had impaired LV perfusion. In the latter, flow in the basal region was increased in the acute state (1.5 ± 0.1 vs. 1.2 ± 0.1 mL/g/minRPP-corrected, P < 0.01), whereas midventricular (1.7 ± 0.1 vs. 1.6 ± 0.1 mL/g/minRPP-corrected, P = 0.21) and apical (1.4 ± 0.1 vs. 1.5 ± 0.1 mL/g/minRPP-corrected, P = 0.36) flow was unchanged between acute and follow-up, and within normal range.CONCLUSION: Our results suggest an abnormal LV perfusion distribution in the acute state of TTC with basal hyperperfusion and a normoperfused akinetic region. The proportion of patients without visualized perfusion abnormalities in the acute state may represent a subgroup with fast remission.

KW - Aged

KW - Biomarkers

KW - Coronary Angiography

KW - Echocardiography

KW - Electrocardiography

KW - Female

KW - Humans

KW - Hyperemia

KW - Magnetic Resonance Imaging

KW - Male

KW - Myocardial Perfusion Imaging

KW - Positron-Emission Tomography

KW - Radiopharmaceuticals

KW - Rubidium Radioisotopes

KW - Takotsubo Cardiomyopathy

KW - Ventricular Dysfunction, Left

U2 - 10.1093/ehjci/jev065

DO - 10.1093/ehjci/jev065

M3 - Journal article

C2 - 25851324

VL - 16

SP - 1162

EP - 1169

JO - European Heart Journal Cardiovascular Imaging

JF - European Heart Journal Cardiovascular Imaging

SN - 2047-2404

IS - 10

ER -

ID: 162714479